卓悦控股(00653.HK)與Apex Boom就醫美業務訂立戰略合作諒解備忘錄
格隆匯12月8日丨卓悦控股(00653.HK)公吿,於2021年12月8日,公司的全資附屬公司卓悦健康與Apex Boom Limited 就醫美市場的業務發展合作訂立戰略合作諒解備忘錄。諒解備忘錄不構成對訂約方具法律約束力的協議。
集團於香港、澳門及中國主要從事美容保健產品零售及批發。董事認為,可能合作可為集團提供日後開發醫美市場及擴張集團的業務及收益基礎的機會,其與集團的業務發展策略一致。
Apex Boom為一間於香港註冊成立的有限公司,於公佈日期由黃和遠醫生全資擁有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.